Related Experiment Videos
The use of fazadinium in children. An electromyographic study
Insights
Fazadinium provides effective neuromuscular blockade in children, comparable to pancuronium, with dose-dependent effects. This potent neuromuscular blocking agent is suitable for various surgical durations under light anesthesia.
Area of Science:
- Anesthesiology
- Pediatric Pharmacology
- Neuromuscular Pharmacology
Background:
- Neuromuscular blocking agents are crucial in pediatric anesthesia.
- Evaluating new agents like fazadinium is essential for optimizing anesthetic care.
- Pancuronium is a commonly used reference neuromuscular blocker.
Purpose of the Study:
- To assess the efficacy and safety of fazadinium in pediatric patients.
- To compare the neuromuscular blocking effects of fazadinium with pancuronium.
- To determine optimal dosing for fazadinium in children.
Main Methods:
- A randomized study involving 64 children (6 months to 12 years).
- Administration of varying doses of fazadinium (0.75, 1.0, 1.25 mg/kg) and pancuronium (0.1 mg/kg).
- Electromyographic monitoring of neuromuscular transmission using train-of-four stimuli.
Main Results:
- Fazadinium demonstrated dose-dependent increases in speed, duration, and depth of neuromuscular blockade.
- A fazadinium dose of 1.0-1.25 mg/kg provided satisfactory relaxation for medium to long procedures.
- Fazadinium's effects were comparable to pancuronium (0.1 mg/kg), excluding onset speed; blockade was not age-dependent.
- Train-of-four ratio proved more sensitive for monitoring recovery than single twitch.
Conclusions:
- Fazadinium is a potent neuromuscular blocker effective for pediatric surgery.
- Dosing of 1.0-1.25 mg/kg fazadinium is recommended for adequate surgical relaxation.
- Fazadinium offers a viable alternative to pancuronium in pediatric anesthesia.
Abstract:
To evaluate the use fazadinium in children and to compare it with pancuronium, 64 children aged 6 months to 12 yr received fazadinium 0.75, 1.0, 1.25 mg kg-1 and pancuronium 0.1 mg kg-1 in groups of 16. Neuromuscular transmission was evaluated electromyographically using train-of-four stimuli. The times to first effect, maximum effect, first sign of recovery, reversal and full recovery after reversal were recorded and neuromuscular transmission was monitored continuously until complete recovery was obtained. Duration of satisfactory clinical relaxation and neuromuscular transmission when relaxation became inadequate were recorded. The speed, duration and depth of effect, and the duration and degree of neuromuscular blockade increased significantly depending on dose. Fazadinium was found to be a potent drug providing satisfactory relaxation in a dose of 1.0-1.25 mg kg-1 for operations of medium to long duration in children under light halothane anaesthesia. When relaxation became inadequate neuromuscular transmission still showed marked depression. Duration and degree of blockade of fazadinium and pancuronium were not age-dependent. In all groups the neuromuscular blockade was reversed easily. Apart from the speed of onset of action, pancuronium 0.1 mg kg-1 corresponded to a dose of fazadinium between 1.0 and 1.25 mg kg-1. Train-of-four ratio was found to be more sensitive than single twitch as an index of the recovery of transmission during recovery and in the period after operation.